IF
BLUE

Ironwood Financial’s bluebird bio BLUE Stock Holding History

Ironwood Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6
Closed -$8K – 264
2017
Q2 		$8K Hold
6
– – 0.01% 179
2017
Q1 		$7K Hold
6
– – ﹤0.01% 184
2016
Q4 		$5K Hold
6
– – ﹤0.01% 202
2016
Q3 		$5K Hold
6
– – ﹤0.01% 199
2016
Q2 		$3K Hold
6
– – ﹤0.01% 225
2016
Q1 		$3K Buy
+6
New +$3.69K ﹤0.01% 229
2015
Q3 		$6K Sell
6
-4
-40% -$7.29K ﹤0.01% 240
2015
Q2 		$21K Hold
10
– – 0.01% 160
2015
Q1 		$15K Hold
10
– – 0.01% 178
2014
Q4 		$11K Buy
+10
New +$6.68K 0.01% 173

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ironwood Financial's BLUE Position: Q3 2017 in Review

Ironwood Financial sold out of bluebird bio (BLUE) in Q3 2017, closing a stake of 6 shares — an estimated $8K sold.

Ironwood Financial first reported a position in BLUE in Q4 2014 and held it in 10 quarters. The position peaked at $21K in Q2 2015. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

  • Ironwood Financial reported no remaining bluebird bio position as of Q3 2017 after selling out during the quarter.
  • Ironwood Financial sold 6 bluebird bio shares in Q3 2017, an estimated $8K.
  • Ironwood Financial first reported a position in bluebird bio in Q4 2014 and held it in 10 quarters.
  • Ironwood Financial's bluebird bio position peaked at $21K in Q2 2015.
  • 243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Ironwood Financial's 13F filing for Q3 2017, filed 3 Nov 2017.